![]() |
|
|||||||
![]() |
|
|
أدوات الموضوع | انواع عرض الموضوع |
|
#1
|
|||
|
|||
|
FRANKFURT (Reuters) - Kidney dialysis provider Fresenius Medical Care (FMC) expects more than 70 percent of eligible U.S. patients to have switched to cheaper alternative anemia treatment Mircera by the end of March, the German group's chief executive said. ![]() ??????? ??????: FMC aims for 110,000 U.S. patients to be on Mircera in first-quarter || ??????: ahlam1399 || ??????: اسم منتداك
|
![]() |
|
|